RecruitingNCT03537794

Characterizing Synaptic Density in Treatment Resistant Depression


Sponsor

Unity Health Toronto

Enrollment

45 participants

Start Date

Aug 22, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to better understand how certain brain systems work in people with depression, especially in those whose symptoms have not improved with antidepressant treatments. The investigators are particularly interested in synaptic density, which helps to understand how different parts of the brain communicate with one another. Synaptic density levels have implications on overall brain function and cognition. By comparing brain function in people with treatment-resistant depression, people with treatment-responsive depression, and healthy controls, investigators hope to better understand why some individuals do not respond to antidepressants. This research may help guide the development of more effective treatments in the future.


Eligibility

Min Age: 25 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying how dopamine receptors in the brain differ between people who respond to antidepressant medications and those who do not (called treatment-resistant depression), using a specialized brain scan called PET imaging. **You may be eligible if...** - You are between 25 and 55 years old - You have been diagnosed with a major depressive episode as part of major depressive disorder (MDD) - Your depression is moderate to severe based on a standard rating scale - You have been off all psychiatric medications for a specific period before the scan - You can safely undergo an MRI scan (no metal implants, pacemakers, etc.) - Healthy volunteers without any psychiatric history are also welcome to participate as comparison participants **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have an untreated or urgent medical condition - You have a recent history (within 6 months) of drug or alcohol problems - You have a history of psychosis or schizophrenia - You are currently taking any psychiatric medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPET scans

PET scans and PHNO scans


Locations(1)

Unity Health Toronto

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03537794


Related Trials